Pan-HDAC inhibitor LAQ824 inhibits the progression of pancreatic ductal adenocarcinoma and suppresses immune escape by promoting antigen presentation

Authors:

Abstract
No abstract available
Funding Information
  • Capital Health Research and Development of Special Fund (Z201100005520090)
  • National Key Research and Development Program of China
  • National Key Research and Development Program of China Stem Cell and Translational Research (2021YFA1201102)

This publication has 59 references indexed in Scilit: